Lv43
640 积分 2023-05-17 加入
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction
1天前
已完结
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry
1天前
已完结
Safety and efficacy of aficamten in patients with non‐obstructive hypertrophic cardiomyopathy: A 36‐week analysis from FOREST‐HCM
1天前
已完结
Natriuretic peptides, kidney function and clinical outcomes in heart failure with preserved ejection fraction
2个月前
已完结
Myosin-Inhibitor Mavacamten Acutely Enhances Cardiomyocyte Diastolic Compliance in Heart Failure With Preserved Ejection Fraction
2个月前
已完结
Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Tafamidis in Cardiac Amyloidosis
2个月前
已完结
Differential Association of Transthyretin Stability with Variant and Wild-Type Transthyretin Amyloid Cardiomyopathy
2个月前
已完结
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
2个月前
已完结
Construction of a Near-Infrared Fluorescent Probe for Dynamic Monitoring and Early Diagnosis of Heart Failure
2个月前
已完结
Detect and define ventricular arrhythmia substrates in hypertrophic cardiomyopathy
3个月前
已完结
皖公网安备34019202002308
